|
ANO6 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.88910000040477E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.74569999958452E-07 |
| Normal-vs-Stage2 |
5.916400E-02 |
| Normal-vs-Stage3 |
3.839000E-03 |
| Normal-vs-Stage4 |
8.779600E-03 |
| Stage1-vs-Stage2 |
3.086400E-01 |
| Stage1-vs-Stage3 |
2.743000E-01 |
| Stage1-vs-Stage4 |
4.113600E-01 |
| Stage2-vs-Stage3 |
8.569400E-01 |
| Stage2-vs-Stage4 |
7.952600E-01 |
| Stage3-vs-Stage4 |
9.093800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.74259999763393E-08 |
| Normal-vs-AfricanAmerican |
8.855700E-02 |
| Normal-vs-Asian |
2.349600E-01 |
| Caucasian-vs-AfricanAmerican |
3.20140003395863E-09 |
| Caucasian-vs-Asian |
8.676000E-01 |
| AfricanAmerican-vs-Asian |
2.777700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.74959999999347E-05 |
| Normal-vs-Female |
7.85949999970725E-07 |
| Male-vs-Female |
1.862450E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.672800E-01 |
| Normal-vs-Age(41-60Yrs) |
3.0744000000249E-06 |
| Normal-vs-Age(61-80Yrs) |
1.67960999999384E-05 |
| Normal-vs-Age(81-100Yrs) |
3.188200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.873570E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.111000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.505400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.060000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.071600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.773200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.996110E-03 |
| Normal-vs-Grade 2 |
9.88860000550318E-08 |
| Normal-vs-Grade 3 |
1.168730E-04 |
| Normal-vs-Grade 4 |
2.440200E-01 |
| Grade 1-vs-Grade 2 |
9.017600E-01 |
| Grade 1-vs-Grade 3 |
6.608200E-01 |
| Grade 1-vs-Grade 4 |
1.482970E-01 |
| Grade 2-vs-Grade 3 |
3.313000E-01 |
| Grade 2-vs-Grade 4 |
8.657700E-03 |
| Grade 3-vs-Grade 4 |
8.589600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.56863452519474E-12 |
| Normal-vs-ccB subtype |
8.301000E-03 |
| ccA subtype-vs-ccB subtype |
1.383040E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.32210000023537E-07 |
| Normal-vs-N1 |
2.579800E-01 |
| N0-vs-N1 |
8.615600E-01 |
|
|
